KELLY DAYTON: Open Payments
NPI 1801311170 · GOODLETTSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 121 payments from 21 companies in 2025. Trend: 2023 $1,588 · 2024 $1,766 · 2025 $1,986
Food & beverage: $1,986
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $388 |
| ABBVIE INC. | 31 | $309 |
| PFIZER INC. | 14 | $236 |
| Lilly USA, LLC | 13 | $192 |
| Astellas Pharma US Inc | 7 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Axsome Therapeutics, Inc. | 3 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Neurocrine BioSciences, Inc. | 2 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
Products named: Ozempic, NURTEC ODT, UBRELVY, Wegovy, Veozah, QULIPTA, CAPLYTA, Auvelity.
Industry payments across TN — which companies pay providers there.
